首页 > 市场调查报告书 > 医疗设备

核子医学

市场调查报告书

商品编码

1471971

质子治疗系统市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按设定类型、应用和地理位置

Proton Therapy Systems Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Setup Type, Application, and Geography

出版日期: 2024年03月13日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格

简介目录

质子治疗系统市场规模预计将从2022年的12.6亿美元成长到2030年的44.4亿美元；预计2022年至2030年复合年增长率为17.0%。

质子治疗系统市场的市场驱动因素

癌症的高盛行率和对癌症先进治疗的需求增加了对质子放射治疗的需求，推动了质子治疗系统市场的成长。根据国际癌症研究机构 (IARC) 的数据，2022 年肺癌、乳癌和摄护腺癌的发生率最高。根据IARC 的估计，癌症总病例数预计将从2022 年的1,998 万例跃升至2030 年的2,371 万例和2045 年的3,097 万例。、和喉癌）和脑癌具有精确的治疗要求，这导致对调强质子治疗（IMPT）等先进治疗方法的需求很高。在传统的放射治疗中，例如X射线放射治疗，肿瘤周围的健康组织也会受到一定剂量的辐射，这会导致副作用并可能导致继发性癌症。然而，质子治疗有助于有效治疗大脑、头颈区域的复杂肿瘤，同时最大限度地减少对附近组织的附带损害。因此，癌症的高盛行率和对先进治疗的需求增加了对质子放射治疗的需求，推动了质子治疗系统市场的成长。

质子治疗系统市场的机会

印度、中国、阿根廷、巴西、阿联酋和南非等新兴国家预计将为质子治疗系统市场参与者提供巨大的成长机会，因为可支配收入增加、癌症患者人口不断增加、研发活动增加、医疗基础设施改善、医疗保健基础设施不断增长、与已开发国家相比，人们对疾病的认识和指导方针相对宽鬆。这显示质子治疗系统市场的实力。随着这些国家癌症发生率的上升，对各种质子疗法和其他癌症治疗方案的需求更大。此外，这些国家的政府正致力于增加更多人口获得有效和尖端医疗服务的机会，并提高报销范围。人均医疗保健支出的快速增长以及公众对负担得起的医疗保健服务的需求不断增长，推动了这些国家医疗保健产品（包括癌症治疗设备）的扩张。例如，根据世界经济论坛的数据，截至 2022 年，俄罗斯、巴西、中国、印度和南非合计占全球卫生支出的三分之一。根据世界银行的数据，2018年至2019年，印度和中国的医疗支出分别成长了3.01%和5.35%。时期。

质子治疗系统市场：细分概述

市场依设定类型分为单间和多间。多房间细分市场在 2022 年占据最大的市场份额，单房间细分市场预计在预测期内复合年增长率最高。质子治疗系统市场依应用分为脑部及中枢神经系统癌症、头颈癌、摄护腺癌、乳癌、肺癌、胃肠道癌症等。到 2022 年，大脑和中枢神经系统癌症领域将占据最大的质子治疗系统市场份额，预计在预测期内复合年增长率最高。

质子治疗系统市场：地理概述

据估计，2022 年至 2030 年亚太地区的复合年增长率最高。印度和中国等亚太国家拥有质子治疗系统市场的巨大成长潜力。 2022年，北美占据最大的市场份额。最新医疗设备的日益接受和采用、癌症的高盛行率以及主要参与者的产品创新都有助于北美质子治疗系统市场规模的扩大。根据美国癌症协会估计，2023 年美国新增约 195 万癌症病例和约 61 万癌症相关死亡病例，较 2020 年报告的 160 万癌症病例和 60 万死亡人数显着增加。截至2023年底，美国拥有全球质子治疗系统数量最多的国家，拥有46个质子治疗设施。因此，癌症的高盛行率和质子治疗系统的大量安装有利于质子治疗系统市场的发展。

在准备质子治疗系统市场报告时提到的一些主要一手和二手来源包括世界银行数据、国家医疗服务体系 (NHS)、FDA（食品和药物管理局）、EMA（欧洲药品管理局）和WHO（世界卫生组织）。

欧洲
- 德国
- 法国
- 义大利
- 西班牙
- 英国
- 欧洲其他地区
亚太
- 澳洲
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区

第 10 章：产业格局

併购
协议、合作、合资企业
新产品发布
扩张和其他策略发展

第 11 章：竞争格局

关键参与者的热图分析
公司定位与专注

第 12 章：质子治疗系统市场 - 主要公司概况

Varian Medical Systems Inc
Hitachi Ltd
Sumitomo Heavy Industries Ltd
Ion Beam Applications SA
Mevion Medical Systems
Provision Healthcare LLC
ProTom International
Optivus Proton Therapy Inc
Advanced Oncotherapy plc
B dot Medical Inc

第 13 章：附录

简介目录

Product Code: TIPHE100001160

The proton therapy systems market size is expected to grow from US$ 1.26 billion in 2022 to US$ 4.44 billion by 2030; it is anticipated to record a CAGR of 17.0% from 2022 to 2030.

Market Drivers of the Proton Therapy Systems Market

The high prevalence of cancer and demand for advanced treatments for cancers boost the demand for proton-based radiotherapy, fueling the proton therapy systems market growth. As per the International Agency for Research on Cancer (IARC), lung, breast, and prostate cancer types had the highest incidence rate in 2022. These diseases have an age-standardized rate of 23.6, 47.1, and 29.4 cases per 100,000 population, respectively. According to the estimates by IARC, the number of total cancer cases is expected to jump from 19.98 million in 2022 to 23.71 million by 2030 and 30.97 million by 2045. Various cancer conditions, such as head and neck cancers (nasal, oral, eye, and larynx) and brain cancers have precise treatment requirements, which results in a high demand for advanced treatment approaches such as intensity-modulated proton therapy (IMPT). In traditional radiation therapies, such as X-ray radiation therapy, the healthy tissue around the tumor also receives a dose of radiation, which leads to side effects and may cause secondary cancers. However, proton therapy aids in the effective treatment of complicated tumors in the brain, and head and neck region while minimizing the collateral damage to nearby tissues. Thus, the high prevalence of cancer and demand for advanced treatments boost the demand for proton-based radiotherapy, fueling the proton therapy systems market growth.

Opportunities in the Proton Therapy Systems Market

Emerging countries such as India, China, Argentina, Brazil, UAE, and South Africa are expected to offer significant growth opportunities for proton therapy systems market players due to rising disposable incomes, expanding cancer patient population, increasing R&D activities, improving healthcare infrastructure, growing disease awareness, and relatively lenient guidelines compared to developed countries. This is an indication of strength in the proton therapy systems market. As cancer incidence rises in these countries, there is a greater demand for various proton therapy and other cancer treatment options. Furthermore, the governments of these countries are focusing on increasing access to effective and cutting-edge healthcare services for a larger proportion of their populations and improving reimbursement coverage. The expansion of healthcare products (including cancer treatment devices) across these nations is driven by the quick increase in per-capita healthcare spending and the growing public demand for affordable healthcare services. For instance, According to the World Economic Forum, as of 2022, Russia, Brazil, China, India, and South Africa collectively accounted for a third of global health spending. As per the World Bank, health spending in India and China increased by 3.01% and 5.35%, respectively, from 2018 to 2019. Thus, the increasing healthcare expenditure in emerging countries will likely provide opportunities for the proton therapy systems market growth during the forecast period.

Proton Therapy Systems Market: Segmental Overview

The market is bifurcated by setup type into single room and multi room. The multi room segment held the largest market share in 2022 and single room segment is anticipated to register the highest CAGR during the forecast period. The proton therapy systems market, by application, is categorized into brain and central nervous system cancer, head and neck cancer, prostate cancer, breast cancer, lung cancer, gastrointestinal cancer, and others. The brain and central nervous system cancer segment held the largest proton therapy systems market share in 2022 and it is anticipated to register the highest CAGR during the forecast period.

Proton Therapy Systems Market: Geographical Overview

Asia Pacific is estimated to register the highest CAGR during 2022-2030. Countries in the Asia Pacific, such as India and China, hold significant potential for the growth of the proton therapy systems market. In 2022, North America accounted for the largest market share. The growing acceptance and adoption of the latest medical devices, the high prevalence of cancer, and product innovations by key players contribute to the expansion of the proton therapy systems market size in North America. According to the American Cancer Society estimates, the US recorded ~1.95 million new cancer cases and ~0.61 million mortalities related to the disease in 2023, exhibiting a significant increase from 1.60 million cancer cases and 0.60 million deaths reported in 2020. As per the Particle Therapy Co-Operative Group, at the end of 2023, the US had the highest number of proton therapy systems globally, with 46 proton therapy treatment facilities. Thus, the high prevalence of cancer and the high number of installed proton therapy systems favor the proton therapy systems market progress.

A few of the major primary and secondary sources referred to while preparing the report on the proton therapy systems market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Proton Therapy Systems Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Proton Therapy Systems Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Proton Therapy Systems Market - Global Market Analysis

6.1 Proton Therapy Systems - Global Market Overview
6.2 Proton Therapy Systems - Global Market and Forecast to 2030

7. Proton Therapy Systems Market - Revenue Analysis (USD Million) - By Set-up Type, 2020-2030

7.1 Overview
7.2 Single Room
7.3 Multi Room

8. Proton Therapy Systems Market - Revenue Analysis (USD Million) - By Application, 2020-2030

8.1 Overview
8.2 Brain and Central Nervous System Cancer
8.3 Head and Neck Cancer
8.4 Prostate Cancer
8.5 Breast Cancer
8.6 Lung Cancer
8.7 Gastrointestinal Cancer
8.8 Others

9. Proton Therapy Systems Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

9.1 North America
- 9.1.1 North America Proton Therapy Systems Market Overview
- 9.1.2 North America Proton Therapy Systems Market Revenue and Forecasts to 2030
- 9.1.3 North America Proton Therapy Systems Market Revenue and Forecasts and Analysis - By Set-up Type
- 9.1.4 North America Proton Therapy Systems Market Revenue and Forecasts and Analysis - By Application
- 9.1.5 North America Proton Therapy Systems Market Revenue and Forecasts and Analysis - By Countries
  - 9.1.5.1 United States Proton Therapy Systems Market
    - 9.1.5.1.1 United States Proton Therapy Systems Market, by Set-up Type
    - 9.1.5.1.2 United States Proton Therapy Systems Market, by Application
  - 9.1.5.2 Canada Proton Therapy Systems Market
    - 9.1.5.2.1 Canada Proton Therapy Systems Market, by Set-up Type
    - 9.1.5.2.2 Canada Proton Therapy Systems Market, by Application
  - 9.1.5.3 Mexico Proton Therapy Systems Market
    - 9.1.5.3.1 Mexico Proton Therapy Systems Market, by Set-up Type
    - 9.1.5.3.2 Mexico Proton Therapy Systems Market, by Application

Note - Similar analysis would be provided for below mentioned regions/countries

9.2 Europe
- 9.2.1 Germany
- 9.2.2 France
- 9.2.3 Italy
- 9.2.4 Spain
- 9.2.5 United Kingdom
- 9.2.6 Rest of Europe
9.3 Asia-Pacific
- 9.3.1 Australia
- 9.3.2 China
- 9.3.3 India
- 9.3.4 Japan
- 9.3.5 South Korea
- 9.3.6 Rest of Asia-Pacific
9.4 Middle East and Africa
- 9.4.1 South Africa
- 9.4.2 Saudi Arabia
- 9.4.3 U.A.E
- 9.4.4 Rest of Middle East and Africa
9.5 South and Central America
- 9.5.1 Brazil
- 9.5.2 Argentina
- 9.5.3 Rest of South and Central America

10. Industry Landscape

10.1 Mergers and Acquisitions
10.2 Agreements, Collaborations, Joint Ventures
10.3 New Product Launches
10.4 Expansions and Other Strategic Developments

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players
11.2 Company Positioning and Concentration

12. Proton Therapy Systems Market - Key Company Profiles

12.1 Varian Medical Systems Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments

Note - Similar information would be provided for below list of companies